(Q44097753)

29 November 2017

title

High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia (English)

1 reference

29 November 2017

0 references

coronary artery disease

1 reference

Melissa A Austin

1

1 reference

29 November 2017

Ron L Zimmern

series ordinal

2

1 reference

29 November 2017

Steve E Humphries

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

4

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

275-278

1 reference

https://scigraph.springernature.com/pub.10.1097/00125817-200207000-00005

29 November 2017

exact match

0 references

cites work

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Estimating the efficacy and efficiency of cascade genetic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

An updated coronary risk profile. A statement for health professionals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

A simple computer program for guiding management of cardiovascular risk factors and prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Established and emerging cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Familial hypercholesterolaemia: a pilot study of parents' and children's concerns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Genetic testing for familial hypercholesterolaemia: practical and ethical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL receptor adaptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

Treatment of early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

The psychological functioning of children with hypercholesterolemia and their families. A preliminary investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00125817-200207000-00005

10.1097/00125817-200207000-00005

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

29 November 2017

1026039671

0 references

1 reference